Open AccessSympathometabolic profile of a fixed combination of lercanidipine with enalapril in the treatment of obese hypertensive patients (study review)
Author(s) -
П. О. Лазарєв
Publication year - 2021
Publication title -
lìki ukraïni
Language(s) - English
Resource type - Journals
ISSN - 1997-9894
DOI - 10.37987/1997-9894.2021.8(254).245830
Subject(s) - lercanidipine , enalapril , concomitant , medicine , angiotensin converting enzyme , fixed dose combination , combination therapy , cardiology , calcium channel , pharmacology , urology , calcium , blood pressure
The publication highlights the main possibilities of fixed combinations of angiotensin-converting enzyme inhibitors with calcium channel blockers in the treatment of hypertension and the advantages of the combination of enalapril 20 mg / lercanidipine 10 mg in terms of sympathomodulatory properties. Clinical data are provided that indicate the benefit of using this combination in patients with hypertension and concomitant obesity